Rosuvastatin NDC 82009-189

Product information

Brand name (proprietary)

Rosuvastatin

Generic name (nonproprietary)

rosuvastatin

Active ingredients

Rosuvastatin calcium — 10 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

Quallent Pharmaceuticals Health LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 206465

Marketing start

Dec 15, 2025

Listing expires

Dec 31, 2027

Other FDA classes

Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)

Identifiers

Product ID 82009-189_0d12ae85-71bd-4818-a82d-fd068530bd87SPL ID 0d12ae85-71bd-4818-a82d-fd068530bd87SPL set ID 0d12ae85-71bd-4818-a82d-fd068530bd87RxCUI 859419, 859424, 859747, 859751UNII 83MVU38M7QUPC 0382009190051, 0382009191058

Pharmacologic class

HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482009018905 followed by a unit qualifier and the quantity Copy

Package 82009-0189-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 206465

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.